Very early development of typical signs of Kawasaki Disease with transient coronary involvement.

Main Article Content

Danilo Buonsenso
Danilo Buonsenso, MD, Catholic University of Sacred Heart—A. Gemelli Hospital, Department of Pediatrics, Pediatric Infectious Disease Unit, Largo A. Gemelli 8, 00168 Rome, Italy. E-mail:

Sebastian Cristaldi
Ospedale Pediatrico Bambino Gesù, Roma

Antonino Reale
Ospedale Pediatrico Bambino Gesù, Roma

Isabella Tarissi de Jacobis
Ospedale Pediatrico Bambino Gesù, Roma

Laura Granata
Ospedale Pediatrico Bambino Gesù, Roma

Alessandra Marchesi
Ospedale Pediatrico Bambino Gesù, Roma

Keywords

kawasaki disease, coronary artery

Abstract

Kawasaki disease (KD) is an acute, self-limited, inflammatory disease affecting medium-sized arteries and particularly the coronary arteries in about 25% of untreated cases. KD is a clinical diagnosis based on the presence of ?5 days of fever and the presence of ?4 of the 5 principal clinical criteria. We described, for the first time to our knowledge, a case of a very early development (on day 1) of typical KD with transient coronary involvement, diagnosed on day 2 of disease and treated with aspirin and steroids on day 3, with complete resolution of clinical signs and coronary involvement.

Downloads

Download data is not yet available.


Abstract 1803
PDF Downloads 513
HTML Downloads 189

References

1- Kuo HC, Hsu YW, Wu MS, et al. Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease. J. Microbiol. Immunol. Infect. 2016;49:1e7.
2- Moffett BS, Syblik D, Denfield S, et al. Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database. Pediatr. Cardiol. 2015;36:374e8.
3- Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009e2010 nationwide survey. J. Epidemiol. 2012;22:216e21.
4- Kim GB, Han JW, Park YW, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr. Infect. Dis. J. 2014;33:24-7
5- Falcini F, Capannini S, Rigante D. Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Pediatr. Rheumatol. 2011;9:17.
6- Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747–2771.
7- McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135:e927–e999
8- Shulman ST. Is there a role for corticosteroids in Kawasaki disease? J. Pediatr. 2003;142:601–603.
9- Yang TJ, Lin MT, Lu CY, et al. The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness. J. Microbiol. Immunol. Infect. 2017;S1684-1182(17)30195-0.
10- Pinches H, Dobbins K, Cantrell S, et al. Asymptomatic Kawasaki Disease in a 3-Month-Old Infant. Pediatrics. 2016;138(2):e20153936

Article Sidebar

PDF HTML
Published
Jun 20, 2018
DOI https://doi.org/10.4084/mjhid.2018.037

Article Details

How to Cite

Buonsenso, D. (2018) “Very early development of typical signs of Kawasaki Disease with transient coronary involvement”., Mediterranean Journal of Hematology and Infectious Diseases, 10(1), p. e2018037. doi: 10.4084/mjhid.2018.037.
Issue
Vol. 10 (2018): Review Articles, Original Articles, Scientific Letters, Case Reports
Section
Case Reports

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.